Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




CT-Guided, Robotic System Enables Fast, Accurate and Hands-Free Insertion and Steering of Ablation Probes

By HospiMedica International staff writers
Posted on 24 May 2022

A robotic system integrates image guided planning and real time monitoring with precise robotic insertion and non-linear steering to deliver various instruments to a desired target in the body with enhanced accuracy and consistency. More...

XACT Robotics (Caesarea, Israel) has received US Food and Drug Administration (FDA) clearance for a modification to its cleared XACT ACE Robotic System designed to support robotic insertion and steering of ablation probes during ablation clinical procedures. This clearance expands the company’s already broad indication for CT-guided percutaneous procedures with over 200 clinical cases performed to date in multiple medical centers. The comprehensive XACT ACE Robotic System is the first and only technology that combines image-based procedure planning and real time monitoring with hands free precise robotic insertion and non-linear steering.

Using the XACT ACE Robotic System for ablation probe insertion and steering, health systems now have the potential to save time with fast and accurate probe placement​, contributing to the overall procedure efficiency and success. The proprietary robotic insertion and non-linear steering precisely delivers instruments to a desired target in the body - overcoming the size, depth, movement, or obstructions that may be in the path. The system has been proven to achieve unparalleled 1.7mm tip to target average accuracy upon first insertion, with a less than 8.5-minute average skin to target time. This has the potential to enhance a user’s ability to provide more timely and accurate diagnoses and treatment for patients, helping to reduce the “watchful waiting” period and improve outcomes.

“Ablation procedures are challenging to many users in terms of the accuracy and time required to place the ablation probes” said Harel Gadot, founder and executive chairman of XACT Robotics. “The proven ability of our system to reach relatively small targets, regardless of target movement or obstacles, with unparalleled accuracy and one insertion to target will provide better patient outcomes with greater efficiencies. Moreover, with the addition of the newly cleared ablation capabilities, we can now provide even more value to our partners by increasing the utilization of our system."

Related Links:
XACT Robotics 


Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Fetal Monitor
BT-380
Medical Adhesive
MED 5570U
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.